-       Clinical Trials 
- April 2025
-  80 Pages 
- Global 
   From       €1424EUR$1,600USD£1,253GBP 
      €1780EUR$2,000USD£1,567GBP 
          -       Report 
- July 2025
-  150 Pages 
- Global 
   From       €5295EUR$5,950USD£4,661GBP 
            -       Report 
- October 2025
-  185 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  194 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
            -       Report 
- August 2025
-  199 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
           -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
            -       Clinical Trials 
- April 2025
-  50 Pages 
- Global 
   From       €1068EUR$1,200USD£940GBP 
      €1335EUR$1,500USD£1,175GBP 
            -       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €1068EUR$1,200USD£940GBP 
      €1335EUR$1,500USD£1,175GBP 
            -       Clinical Trials 
- April 2025
-  40 Pages 
- Global 
   From       €890EUR$1,000USD£783GBP 
      €1112EUR$1,250USD£979GBP 
          -       Report 
- June 2025
-  400 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- January 2025
-  200 Pages 
- Global 
   From       €4445EUR$4,995USD£3,913GBP 
          -       Report 
- October 2023
-  145 Pages 
- Global 
   From       €2803EUR$3,150USD£2,467GBP 
            -       Report 
- July 2023
-  135 Pages 
- Global 
   From       €5339EUR$6,000USD£4,700GBP 
      €6674EUR$7,500USD£5,875GBP 
            -       Report 
- June 2024
-  200 Pages 
- Global 
   From       €5660EUR$6,360USD£4,982GBP 
      €7074EUR$7,950USD£6,227GBP 
            -       Report 
- July 2023
-  67 Pages 
- Global 
   From       €2812EUR$3,160USD£2,475GBP 
      €3515EUR$3,950USD£3,094GBP 
          -       Report 
- June 2023
-  92 Pages 
- Asia Pacific 
   From       €1335EUR$1,500USD£1,175GBP 
       
      The Opioid Dependence market is a subset of the Addiction Disorders Drugs market, which includes medications used to treat substance use disorders. Opioid Dependence medications are used to treat individuals with opioid use disorder, a condition characterized by compulsive opioid use despite negative consequences. These medications work by reducing cravings and withdrawal symptoms, and can be used as part of a comprehensive treatment plan. Common medications used to treat opioid dependence include    buprenorphine, methadone, and naltrexone.
Companies in the Opioid Dependence market include Indivior, Reckitt Benckiser, Orexo, and Braeburn Pharmaceuticals. Show Less   Read more